BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 31034570)

  • 1. Hyaluronate gel injection for rectum dose reduction in gynecologic high-dose-rate brachytherapy: initial Japanese experience.
    Kashihara T; Murakami N; Tselis N; Kobayashi K; Tsuchida K; Shima S; Masui K; Yoshida K; Takahashi K; Inaba K; Umezawa R; Igaki H; Ito Y; Kato T; Uno T; Itami J
    J Radiat Res; 2019 Jul; 60(4):501-508. PubMed ID: 31034570
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyaluronic acid gel injection in rectovaginal septum reduced incidence of rectal bleeding in brachytherapy for gynecological malignancies.
    Murakami N; Nakamura S; Kashihara T; Kato T; Shibata Y; Takahashi K; Inaba K; Okuma K; Igaki H; Nakayama Y; Galalae R; Itami J
    Brachytherapy; 2020; 19(2):154-161. PubMed ID: 31879238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effective timing of hyaluronate gel injection in image-guided adaptive brachytherapy for uterine cervical cancer: a proposal of the 'adjusted dose score'.
    Miyata Y; Ogo E; Murotani K; Tsuda N; Suzuki G; Tsuji C; Akeda R; Muraki K; Hattori C; Abe T
    J Radiat Res; 2024 May; 65(3):393-401. PubMed ID: 38739893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [High-dose gynecologic endocavitary brachytherapy. Technical and dosimetric aspects].
    Grillo Ruggieri F; Parietti E; Bistolfi F; Tomassini E; Papadia S; Leonardi S; Siragusa A; Guglielmi M; Brizzi C; Scielzo G
    Radiol Med; 1989 Oct; 78(4):373-9. PubMed ID: 2595028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of interfractional variation of organs and displacement of catheters during high-dose-rate interstitial brachytherapy for gynecologic malignancies.
    Lee S; Rodney E; Traughber B; Biswas T; Colussi V; Podder T
    Brachytherapy; 2017; 16(6):1192-1198. PubMed ID: 28993108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Computed tomography-planned interstitial brachytherapy for locally advanced gynecologic cancer: Outcomes and dosimetric predictors of urinary toxicity.
    Amsbaugh MJ; Bhatt N; Hunter T; Gaskins J; Parker L; Metzinger D; Amsbaugh A; Sowards K; El-Ghamry MN
    Brachytherapy; 2016; 15(1):49-56. PubMed ID: 26614237
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-dose-rate interstitial brachytherapy for gynecologic malignancies--dosimetric changes during treatment period.
    Onoe T; Nose T; Yamashita H; Yoshioka M; Toshiyasu T; Kozuka T; Oguchi M; Nakagawa K
    J Radiat Res; 2013 Jul; 54(4):663-70. PubMed ID: 23297319
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outpatient template-guided permanent interstitial brachytherapy using
    Feddock J; Aryal P; Steber C; Edwards J; Cheek D; Randall M
    Brachytherapy; 2017; 16(2):393-401. PubMed ID: 28139423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors of toxicity after image-guided high-dose-rate interstitial brachytherapy for gynecologic cancer.
    Lee LJ; Viswanathan AN
    Int J Radiat Oncol Biol Phys; 2012 Dec; 84(5):1192-7. PubMed ID: 22592049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterizing the impact of adaptive planning on image-guided perineal interstitial brachytherapy for gynecologic malignancies.
    Gladwish A; Ravi A; Barbera L; Mendez L; Davidson M; D'Alimonte L; D'Souza D; Wronski M; Leung E
    Brachytherapy; 2018; 17(2):352-359. PubMed ID: 29241705
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new perineal template assembly for high-dose-rate interstitial brachytherapy of gynecologic malignancies.
    Höckel M; Müller T
    Radiother Oncol; 1994 Jun; 31(3):262-4. PubMed ID: 8066211
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The clinical impact of removing rectal gas on high-dose-rate brachytherapy dose distributions for gynecologic cancers.
    Vergalasova I; Ennis RD; Sayan M; Liu B; Yue NJ; Hathout L
    J Appl Clin Med Phys; 2021 Feb; 22(2):35-41. PubMed ID: 33440079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison between tandem and ovoids and interstitial gynecologic template brachytherapy dosimetry using a hypothetical computer model.
    Hsu IC; Speight J; Hai J; Vigneault E; Phillips T; Pouliot J
    Int J Radiat Oncol Biol Phys; 2002 Feb; 52(2):538-43. PubMed ID: 11872302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safe dose escalation and reduction of the fraction number of uterine cervical brachytherapy using a gel spacer in the rectovaginal and vesicouterine septum: A planning study.
    Takatsu J; Murakami N; Muramoto Y; Karino T; Oshima M; Kosugi Y; Kawamoto T; Terao Y; Shikama N
    Brachytherapy; 2024; 23(2):115-122. PubMed ID: 38040605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long term experience with 3D image guided brachytherapy and clinical outcome in cervical cancer patients.
    Ribeiro I; Janssen H; De Brabandere M; Nulens A; De Bal D; Vergote I; Van Limbergen E
    Radiother Oncol; 2016 Sep; 120(3):447-454. PubMed ID: 27157510
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of an MR-only interstitial gynecologic brachytherapy workflow using MR-line marker for catheter reconstruction.
    Shaaer A; Paudel M; Smith M; Tonolete F; Nicolae A; Leung E; Ravi A
    Brachytherapy; 2020; 19(5):642-650. PubMed ID: 32712027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dynamics of High Risk Clinical Target Volume reduction during Brachytherapy and impact on its coverage in patients with inoperable cervical cancer.
    Pobijakova M; Scepanovic D; Paluga M; Fekete M; Mardiak J
    Neoplasma; 2018 Mar; 65(3):425-430. PubMed ID: 29788726
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Image and laparoscopic guided interstitial brachytherapy for locally advanced primary or recurrent gynaecological cancer using the adaptive GEC ESTRO target concept.
    Fokdal L; Tanderup K; Nielsen SK; Christensen HK; Røhl L; Pedersen EM; Schønemann NK; Lindegaard JC
    Radiother Oncol; 2011 Sep; 100(3):473-9. PubMed ID: 21924784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Point A vs. HR-CTV D
    Harmon G; Diak A; Shea SM; Yacoub JH; Small W; Harkenrider MM
    Brachytherapy; 2016; 15(6):825-831. PubMed ID: 27693173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-dose-rate interstitial brachytherapy for gynecologic malignancies.
    Beriwal S; Bhatnagar A; Heron DE; Selvaraj R; Mogus R; Kim H; Gerszten K; Kelley J; Edwards RP
    Brachytherapy; 2006; 5(4):218-22. PubMed ID: 17118313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.